Nii Aisuke | Drug Safety Research And Development ; Global Research And Development Nagoya Laboratories Pfizer Ja

スポンサーリンク

概要

• NII Aisukeの詳細を見る
• 同名の論文著者
• Drug Safety Research And Development ; Global Research And Development Nagoya Laboratories Pfizer Jaの論文著者

関連著者

• Ohmi Takashi

  Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.

• KOJIMA Midori

  Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.

• KATO Naoto

  Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.

• HIRANO Daisuke

  Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.

• OCHI Takashi

  Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.

• NII Aisuke

  Drug Safety Research and Development ; Global Research and Development, Nagoya Laboratories, Pfizer

• SHINJO Katsuhiro

  Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.

• EDA Hiroyuki

  Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.

• Hirano Daisuke

  Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.

• Shinjo Katsuhiro

  Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.

• Kato Naoto

  Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.

• Nii Aisuke

  Drug Safety Research And Development ; Global Research And Development Nagoya Laboratories Pfizer Ja

• Eda Hiroyuki

  Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.

• Eda Hiroyuki

  Discovery Biology Research Global Research & Development Nagoya Laboratories Pfizer Japan Inc.

• Kojima Midori

  Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.

• Ochi Takashi

  Discovery Biology Nagoya Laboratories Pfizer Global Research And Development

• Nii Aisuke

  Drug Safety Research & Development Nagoya Laboratories Pfizer Global Research And Development

もっと見る 閉じる

著作論文

• Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A

スポンサーリンク